GO:0009116 nucleoside metabolic process: Transport, Salvage and Nucleotide Synthesis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0009116 nucleoside metabolic process describes all chemical reactions and pathways involving a nucleoside, a nucleobase linked to either beta-D-ribofuranose or 2-deoxy-beta-D-ribofuranose, including adenosine, guanosine, inosine, cytidine, uridine, deoxyadenosine, deoxyguanosine, deoxycytidine and thymidine.
• Nucleoside metabolism is tightly coupled to nucleoside transport across membranes, which is mediated by two major families: the concentrative SLC28 nucleoside transporters and the equilibrative SLC29 nucleoside transporters.
• Nucleoside metabolic intermediates are essential for DNA and RNA synthesis, cellular energy balance, and signaling, and their dysregulation is linked to cancer, viral infections, and mitochondrial diseases.
• Nucleoside-driven specificity has been demonstrated for DNA methyltransferases, linking nucleoside metabolism directly to epigenetic regulation.
• Chemoenzymatic preparation of nucleoside triphosphates provides essential tools for studying nucleoside metabolism and for developing nucleotide-based therapeutics.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of nucleoside metabolic genes and their roles in disease.
Description
Nucleoside metabolic process (GO:0009116) encompasses the chemical reactions and pathways involving a nucleoside, which is a nucleobase linked to either beta-D-ribofuranose (a ribonucleoside) or 2-deoxy-beta-D-ribofuranose (a deoxyribonucleoside). This includes adenosine, guanosine, inosine, cytidine, uridine, and their deoxy counterparts such as deoxyadenosine, deoxyguanosine, deoxycytidine, and thymidine. Nucleosides are central to nucleic acid synthesis, energy metabolism, and cellular signaling, making this process fundamental to all living cells. Research into nucleoside metabolic process has revealed its critical dependence on nucleoside transporters, which regulate the flux of nucleosides and nucleobase analogs across cellular membranes. The concentrative nucleoside transporter family SLC28 and the equilibrative nucleoside transporter family SLC29 are key mediators of this transport, influencing drug uptake and cellular sensitivity to nucleoside analogs. In plants, nucleoside transport and associated metabolism are similarly essential for growth and development. Understanding nucleoside metabolic process is also important for therapeutic development. Nucleoside analogs are widely used as antiviral and anticancer agents, and their efficacy depends on metabolic activation and transport. Moreover, nucleoside-driven specificity of DNA methyltransferases highlights a direct link between nucleoside metabolism and epigenetic regulation. This article provides a comprehensive overview of the ontology, mechanisms, key genes, disease relevance, and research methods for studying GO:0009116.
nucleoside metabolic process At A Glance
| GO ID | GO:0009116 |
|---|---|
| GO term | nucleoside metabolic process |
| Ontology | biological_process |
| Synonym | nucleoside metabolism |
| Major function | Chemical reactions and pathways involving nucleosides, including their synthesis, salvage, interconversion, and degradation |
| Related transporters | SLC28 family (concentrative nucleoside transporters), SLC29 family (equilibrative nucleoside transporters) |
| Key substrates | Adenosine, guanosine, inosine, cytidine, uridine, deoxyadenosine, deoxyguanosine, deoxycytidine, thymidine |
| Associated diseases | Cancer, viral infections, mitochondrial diseases, and disorders of purine/pyrimidine metabolism |
What Is GO:0009116?
GO:0009116 nucleoside metabolic process is defined as the chemical reactions and pathways involving a nucleoside, a nucleobase linked to either beta-D-ribofuranose (a ribonucleoside) or 2-deoxy-beta-D-ribofuranose (a deoxyribonucleoside), e.g. adenosine, guanosine, inosine, cytidine, uridine and deoxyadenosine, deoxyguanosine, deoxycytidine and thymidine (= deoxythymidine).
Why Is nucleoside metabolic process Important in Cell Biology?
Nucleoside metabolic process is essential for fundamental cellular functions, including DNA and RNA synthesis, energy transfer, and signal transduction. It provides the building blocks for nucleic acids and is a target for many antiviral and anticancer drugs, which often require metabolic activation via nucleoside salvage pathways. The process is also intimately linked to nucleoside transport, as the concentrative and equilibrative transporters regulate the intracellular availability of nucleosides and their analogs. In plants, nucleoside transport and metabolism are critical for growth, development, and stress responses. Furthermore, nucleoside-driven specificity of DNA methyltransferases indicates a role in epigenetic regulation, expanding the importance of this process beyond classical nucleotide metabolism.
• Provides precursors for DNA and RNA synthesis, essential for cell proliferation and genome maintenance.
• Regulates cellular energy balance through nucleoside salvage and interconversion pathways.
• Mediates the uptake and efflux of nucleoside analogs used in antiviral and anticancer therapy.
• Influences DNA methylation and epigenetic regulation via nucleoside-driven specificity of DNA methyltransferases.
• Plays a role in plant growth, development, and stress responses through nucleoside transport and metabolism.
• Dysregulation is associated with mitochondrial diseases and disorders of purine and pyrimidine metabolism.
• Serves as a target for chemoenzymatic synthesis of nucleoside triphosphates for research and drug development.
• Nucleoside transporters are determinants of drug sensitivity and resistance in cancer cells.
• Nucleoside metabolic pathways are exploited by viruses for replication, making them antiviral targets.
• Understanding nucleoside metabolism aids in the design of pro-tide drugs and nucleotide prodrugs.
What Happens During nucleoside metabolic process?
Nucleoside transport and uptake
In simple terms: Nucleosides are moved into and out of cells by specialized transporter proteins.
Nucleoside metabolic process begins with the transport of nucleosides across cellular membranes, which is mediated by two major families of transporters: the concentrative nucleoside transporters (SLC28) and the equilibrative nucleoside transporters (SLC29). These transporters regulate the intracellular concentration of nucleosides and their analogs, thereby influencing downstream metabolic pathways and drug efficacy. In plants, nucleoside transport is similarly essential for the distribution of nucleosides and associated metabolites.
Nucleoside salvage and interconversion
In simple terms: Cells recycle nucleosides into nucleotides and convert them between different forms.
Once inside the cell, nucleosides can be salvaged into nucleotides through phosphorylation by nucleoside kinases, or interconverted via nucleoside phosphorylases and deaminases. These reactions are critical for maintaining nucleotide pools for DNA and RNA synthesis and for energy metabolism. The salvage pathway is particularly important in tissues with high turnover, such as the bone marrow and intestinal epithelium.
Nucleoside triphosphate synthesis
In simple terms: Nucleosides are converted into the triphosphate forms that are used to build DNA and RNA.
Nucleoside triphosphates (NTPs) are synthesized from nucleosides through sequential phosphorylation steps. Chemoenzymatic methods have been developed for the preparation of nucleoside triphosphates, which are essential for studying nucleic acid synthesis and for developing nucleotide-based therapeutics. The availability of NTPs directly impacts DNA replication, transcription, and translation.
Nucleoside-driven epigenetic regulation
In simple terms: Nucleosides can influence how DNA is modified, affecting gene expression.
Recent studies have shown that nucleosides can drive the specificity of DNA methyltransferases, linking nucleoside metabolism to epigenetic regulation. This suggests that changes in nucleoside pools can alter DNA methylation patterns, with potential implications for gene expression and disease.
Nucleoside analog activation and drug action
In simple terms: Many drugs are nucleoside analogs that must be metabolized to become active.
Nucleoside analogs used as antiviral and anticancer agents require metabolic activation through the same pathways that process natural nucleosides. For example, aryloxy phosphoramidate triesters (pro-tides) are designed to bypass rate-limiting phosphorylation steps and deliver active nucleotide analogs. The efficacy of these drugs is influenced by nucleoside transporters and metabolic enzymes.
Key Genes Involved in GO:0009116 nucleoside metabolic process
Key genes and proteins involved in nucleoside metabolic process include transporters, kinases, phosphorylases, and deaminases that regulate nucleoside uptake, salvage, and interconversion.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC28A1 | Concentrative nucleoside transporter | Mediates sodium-dependent uptake of nucleosides and analogs |
| SLC28A2 | Concentrative nucleoside transporter | Involved in renal and intestinal nucleoside absorption |
| SLC28A3 | Concentrative nucleoside transporter | Broad specificity for pyrimidine and purine nucleosides |
| SLC29A1 | Equilibrative nucleoside transporter | Facilitates diffusion of nucleosides; target for drug uptake |
| SLC29A2 | Equilibrative nucleoside transporter | Involved in nucleoside transport in various tissues |
| SLC29A3 | Equilibrative nucleoside transporter | Associated with histiocytosis and nucleoside transport |
| DCK | Deoxycytidine kinase | Phosphorylates deoxycytidine and nucleoside analogs |
| HPRT1 | Hypoxanthine phosphoribosyltransferase | Salvage of purine nucleosides |
| ADA | Adenosine deaminase | Degrades adenosine; deficiency causes immunodeficiency |
| PNP | Purine nucleoside phosphorylase | Catalyzes phosphorolysis of purine nucleosides |
| UCK1 | Uridine-cytidine kinase 1 | Phosphorylates uridine and cytidine |
| UCK2 | Uridine-cytidine kinase 2 | Phosphorylates uridine and cytidine in mitochondria |
| CMPK1 | Cytidine monophosphate kinase | Phosphorylates CMP and dCMP |
| NME1 | Nucleoside diphosphate kinase | Synthesizes nucleoside triphosphates |
| NME2 | Nucleoside diphosphate kinase | Synthesizes nucleoside triphosphates |
| DNMT1 | DNA methyltransferase 1 | Nucleoside-driven specificity in DNA methylation |
| DNMT3A | DNA methyltransferase 3A | De novo DNA methylation influenced by nucleosides |
| DNMT3B | DNA methyltransferase 3B | De novo DNA methylation influenced by nucleosides |
How Is nucleoside metabolic process Regulated?
Nucleoside metabolic process is regulated at multiple levels, including transcriptional control of transporter and enzyme genes, allosteric regulation of enzyme activity by nucleotides, and post-translational modifications. The concentrative and equilibrative nucleoside transporters are regulated in response to cellular stress and differentiation signals. In plants, nucleoside transport and metabolism are regulated during development and in response to environmental cues. Additionally, nucleoside-driven specificity of DNA methyltransferases suggests that nucleoside availability can directly influence epigenetic marks.
nucleoside metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ADA | Severe combined immunodeficiency (SCID) | ADA knockout cell line and mouse model |
| PNP | Immunodeficiency and autoimmunity | PNP knockout cell line |
| SLC29A3 | Histiocytosis-lymphadenopathy plus syndrome | SLC29A3 knockout or point mutation models |
| DCK | Mitochondrial DNA depletion syndrome | DCK knockout and rescue models |
| DNMT3A | Cancer and epigenetic dysregulation | Nucleoside-driven methylation assays and DNMT3A mutants |
Nucleoside metabolism in cancer
Altered nucleoside metabolism is a hallmark of cancer, supporting increased nucleotide synthesis for rapid proliferation. Nucleoside transporters are often overexpressed in cancer cells, enhancing the uptake of nucleoside analogs used in chemotherapy. Targeting nucleoside salvage pathways is a therapeutic strategy in hematological malignancies and solid tumors.
Nucleoside metabolism in viral infections
Many viruses depend on host nucleoside metabolism for replication, making nucleoside analogs a cornerstone of antiviral therapy. Drugs such as acyclovir and zidovudine require activation by host nucleoside kinases, and resistance can arise from mutations in these enzymes or transporters.
Nucleoside metabolism in mitochondrial diseases
Mitochondrial DNA synthesis relies on nucleoside salvage enzymes, and defects in these pathways cause mitochondrial depletion syndromes. Mutations in genes such as DCK, TK2, and SLC25A19 lead to severe mitochondrial diseases.
Nucleoside metabolism in immunodeficiency
Deficiencies in adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) cause severe combined immunodeficiency due to accumulation of toxic nucleoside metabolites. These disorders highlight the importance of nucleoside catabolism in immune function.
From nucleoside metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC28A1 affect nucleoside uptake? | SLC28A1 knockout cell line |
| Does a point mutation in DCK alter analog sensitivity? | DCK point mutation knock-in cell line |
| Can overexpression of SLC29A1 enhance drug uptake? | SLC29A1 overexpression cell line |
| Does nucleoside availability affect DNA methylation? | DNMT3A/3B knockout or point mutant cells treated with nucleosides |
| What is the role of ADA in immune cell survival? | ADA knockout and knock-in models |
| Can CRISPR screening identify nucleoside metabolic vulnerabilities? | Genome-wide CRISPR knockout library in cancer cells |
How to Study the nucleoside metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Nucleoside uptake assay | Transport activity | Characterizing SLC28/SLC29 transporters |
| LC-MS metabolomics | Nucleoside and nucleotide levels | Profiling metabolic changes in disease models |
| Enzyme activity assay | Kinase or deaminase activity | Evaluating enzyme variants and drug activation |
| CRISPR knockout screen | Gene essentiality and drug sensitivity | Identifying nucleoside metabolic vulnerabilities |
| RNA-seq | Gene expression changes | Assessing transcriptional regulation of metabolic genes |
| Western blot | Protein expression and modification | Validating knockout or overexpression models |
| Methylation-specific PCR | DNA methylation status | Linking nucleoside metabolism to epigenetics |
| Chemoenzymatic synthesis | Nucleoside triphosphate production | Generating substrates for nucleic acid research |
Nucleoside uptake assays
Radioactive or fluorescent nucleoside analogs are used to measure transport activity in cells expressing specific transporters. These assays help determine kinetic parameters and inhibitor sensitivity.
Metabolomics and nucleotide pool analysis
Liquid chromatography-mass spectrometry (LC-MS) enables quantification of nucleosides and nucleotides in cells and tissues, revealing metabolic flux and pool sizes.
Enzyme activity assays
Recombinant enzymes such as deoxycytidine kinase or adenosine deaminase are assayed for activity using nucleoside substrates and spectrophotometric or radiometric detection.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify genes that modulate sensitivity to nucleoside analogs or affect nucleoside metabolism.
How CRISPR Can Be Used to Study GO:0009116 nucleoside metabolic process
Knockout
CRISPR knockout of nucleoside metabolic genes such as SLC28A1, SLC29A1, DCK, or ADA enables loss-of-function studies to determine their roles in nucleoside uptake, salvage, and drug sensitivity. Knockout cell lines are valuable for validating transporter specificity and metabolic dependencies.
Point Mutation
Point mutations in genes like DCK or DNMT3A can be introduced to mimic clinical variants or to dissect catalytic residues, revealing how specific amino acid changes affect nucleoside metabolism and drug activation.
Knock-in
Knock-in of tagged or reporter versions of nucleoside transporters (e.g., SLC29A1-GFP) allows real-time imaging and localization studies, while knock-in of disease-associated mutations provides isogenic models for functional analysis.
Overexpression
Overexpression of nucleoside transporters or metabolic enzymes can enhance nucleoside uptake and activation of prodrugs, serving as a tool to study gain-of-function effects and to sensitize cells to nucleoside analogs.
How EDITGENE Supports nucleoside metabolic process Research
Researchers studying nucleoside metabolic process-related genes often need to determine whether a candidate gene is causally involved in nucleoside uptake, salvage, or drug response. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models, enabling rigorous functional validation of genes in GO:0009116.
Contact EDITGENE today to design your custom CRISPR model for nucleoside metabolic process research.
Frequently Asked Questions About nucleoside metabolic process
What is nucleoside metabolic process?
Nucleoside metabolic process (GO:0009116) is the set of chemical reactions and pathways involving a nucleoside, a nucleobase linked to a ribose or deoxyribose sugar, including adenosine, guanosine, inosine, cytidine, uridine, and their deoxy forms.
What genes are involved in nucleoside metabolic process?
Key genes include nucleoside transporters (SLC28A1, SLC28A2, SLC28A3, SLC29A1, SLC29A2, SLC29A3), kinases (DCK, UCK1, UCK2), and catabolic enzymes (ADA, PNP).
How is nucleoside metabolic process regulated?
It is regulated by transcriptional control of transporter and enzyme genes, allosteric regulation by nucleotides, and post-translational modifications.
What diseases are associated with nucleoside metabolic process?
Diseases include cancer, viral infections, mitochondrial DNA depletion syndromes, and immunodeficiencies such as ADA deficiency.
What are the main nucleoside transporters?
The two main families are concentrative nucleoside transporters (SLC28) and equilibrative nucleoside transporters (SLC29).
How can I study nucleoside metabolic process in the lab?
Common methods include nucleoside uptake assays, LC-MS metabolomics, enzyme activity assays, and CRISPR-based genetic screens.
What is the role of nucleoside metabolism in cancer?
Cancer cells often upregulate nucleoside metabolism to support proliferation, and nucleoside transporters influence chemotherapy efficacy.
How do nucleoside analogs work?
Nucleoside analogs are prodrugs that require metabolic activation by nucleoside kinases; they inhibit viral or cancer cell replication.
Can CRISPR be used to study nucleoside metabolic genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional studies of nucleoside metabolic genes.
What is the link between nucleoside metabolism and epigenetics?
Nucleosides can drive the specificity of DNA methyltransferases, linking nucleoside metabolism to DNA methylation and gene regulation.
Conclusion
Nucleoside metabolic process (GO:0009116) is a fundamental biological process that encompasses the transport, salvage, interconversion, and utilization of nucleosides. Its importance spans nucleic acid synthesis, energy metabolism, epigenetic regulation, and drug action, with critical roles in cancer, viral infections, and inherited diseases. Understanding the genes and mechanisms involved provides opportunities for therapeutic intervention and biomarker discovery. EDITGENE offers a full range of CRISPR services to facilitate research on nucleoside metabolic process, from knockout and point mutation models to library screening and bioinformatics. By leveraging these tools, researchers can accelerate the translation of nucleoside metabolism discoveries into clinical applications.
References
- 1. Kong W et al.. 2004. Mammalian nucleoside transporters.. Curr Drug Metab 5(1):63-84 PMID: 14965251
- 2. Gade M et al.. 2023. Nucleoside-Driven Specificity of DNA Methyltransferase.. Chembiochem 24(22):e202300094 PMID: 37548117
- 3. Wu W et al.. 2004. Chemoenzymatic preparation of nucleoside triphosphates.. Curr Protoc Nucleic Acid Chem Chapter 13:Unit 13.2 PMID: 18428922
- 4. Cass CE et al.. 1999. Nucleoside transporters of mammalian cells.. Pharm Biotechnol 12:313-52 PMID: 10742981
- 5. Möhlmann T et al.. 2010. Nucleoside transport and associated metabolism.. Plant Biol (Stuttg) 12 Suppl 1:26-34 PMID: 20712618
- 6. Gray JH et al.. 2004. The concentrative nucleoside transporter family, SLC28.. Pflugers Arch 447(5):728-34 PMID: 12856181
- 7. Cahard D et al.. 2004. Aryloxy phosphoramidate triesters as pro-tides.. Mini Rev Med Chem 4(4):371-81 PMID: 15134540
- 8. Baldwin SA et al.. 2004. The equilibrative nucleoside transporter family, SLC29.. Pflugers Arch 447(5):735-43 PMID: 12838422
